Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers

scientific article

Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1027628633
P356DOI10.1186/1740-2557-3-3
P932PMC publication ID1448177
P698PubMed publication ID16573816
P5875ResearchGate publication ID7205352

P2093author name stringCarolyn Hawkins
Paul Gatenby
Colin Andrews
Gytis Danta
Roger Tuck
P2860cites workAntiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic strokeQ28167141
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)Q28174751
Low dose aspirin after ischemic stroke associated with antiphospholipid syndromeQ28196659
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infectionQ28207774
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsQ33341941
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.Q33342481
Features associated with epilepsy in the antiphospholipid syndromeQ33361525
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 PatientsQ33369688
Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 casesQ33408807
The "primary" antiphospholipid syndrome: major clinical and serological features.Q33416915
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorderQ33433089
Primary antiphospholipid syndromeQ33434220
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshopQ33685960
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.Q35189292
Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 monthsQ35563165
Antiphospholipid syndrome: multiple mechanismsQ35775322
Inflammatory response and the endothelium.Q35928642
Stroke and antiphospholipid syndrome: the treatment debateQ36102500
Neurological syndromes associated with antiphospholipid antibodiesQ40688233
Simplified screening procedure for detecting lupus inhibitorQ42841613
Antiphospholipid antibodies and stroke in young womenQ44168396
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeQ44588720
Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groupsQ48090061
Survival and recurrence following stroke. The Framingham studyQ48948948
Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke ProjectQ50606100
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTHQ70897451
Answers to the antiphospholipid-antibody syndrome?Q72619115
The management of thrombosis in the antiphospholipid-antibody syndromeQ72619159
Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndromeQ73686972
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study GroupQ73951222
Consensus guidelines on anti-cardiolipin antibody testing and reportingQ75391670
Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patientsQ77391585
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcerebrovascular diseaseQ3010352
P304page(s)3
P577publication date2006-03-30
P1433published inJournal of autoimmune diseasesQ27720940
P1476titleCerebrovascular disease associated with antiphospholipid antibodies: more questions than answers
P478volume3

Search more.